Vaxart's total assets for Q4 2025 were $186.08M, a decrease of -10.96% from the previous quarter. VXRT total liabilities were $98.28M for the fiscal quarter, a -46.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.